Cibus, Inc. (CBUS) vs Spruce Biosciences, Inc. (SPRB)
A side-by-side comparison of Cibus, Inc. and Spruce Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBUS
Cibus, Inc.
$1.58HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
SPRB
Spruce Biosciences, Inc.
$43.06HealthcareDelayed quote: Oct 6, 2026, 3:29 PM EDT
Total return — CBUS vs SPRB
growth of $100 · dividends reinvested · last 6yCBUS -99.4% (-57.2%/yr)SPRB -96.4% (-42.6%/yr)SPRB compounded faster over this window
Log scale — wide-divergence pair
CBUS SPRB
CBUS vs SPRB: by the numbers
- •CBUS is the larger company ($121M vs $118M market cap).
- •Both run net losses; SPRB's is the smaller (0.00% vs -2258.89% net margin).
Metrics side by side
Valuation
| Metric | CBUS | SPRB |
|---|---|---|
| P/S ratio | 27.74 | N/A |
| P/B ratio | 8.15 | 1.42 |
Profitability
| Metric | CBUS | SPRB |
|---|---|---|
| Gross margin | -62.76% | 0.00% |
| Operating margin | -1853.92% | 0.00% |
| Net margin | -2258.89% | 0.00% |
| ROE | -663.38% | -61.33% |
| ROIC | -17.99% | -50.67% |
Growth (annualized)
| Metric | CBUS | SPRB |
|---|---|---|
| Revenue CAGR (5Y) | -34.28% | N/A |
| Total return CAGR (5Y) | -59.70% | -36.23% |
Frequently asked
- How have CBUS and SPRB total returns compared?
- Over the past 5 years, CBUS delivered -59.70% and SPRB delivered -36.23% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.